Ebola Virus Virulence

The strain of Ebola that has circulated in West Africa for the last year takes longer to kill macaques than the virus that caused an outbreak in Central Africa in 1976.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Ebola virusFLICKR, NIAIDThe Makona strain of Ebola virus that caused the recent outbreak in West Africa, killing more than 11,000 people and sickening even more, is apparently less virulent than the Mayinga strain isolated in Central Africa in 1976, according to a study of macaques published today (June 9) in the US Centers for Disease Control and Prevention journal Emerging Infectious Diseases.

Researchers from the US National Institutes of Health and Bernard-Nocht-Institute for Tropical Medicine in Hamburg, Germany, infected three cynomolgus macaques with the 1976 Mayinga strain and another three with the 2014 Makona strain. Both groups of animals began shedding virus within three days of being infected, but those infected with the Mayinga virus progressed more quickly. On day four, they presented with a rash; by day six, they were extremely ill. These same symptoms appeared in monkeys infected with the Makona virus two days later—at days six and eight, respectively. Liver damage was also delayed by about two days in animals infected with the Makona virus, compared with those infected with the Mayinga strain.

“The main message is . . . it’s certainly not worse ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies